These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6871660)

  • 1. Interaction between spontaneous and electrically induced convulsions and their short- and long-term effects in the abstinence after chronic barbital treatment in the rat.
    Wahlström G
    Brain Res; 1983 May; 266(2):225-32. PubMed ID: 6871660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between electrically induced convulsions and tolerance in the abstinence period after chronic barbital treatments in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1976 Aug; 48(3):239-45. PubMed ID: 823578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1978 Oct; 59(2):123-8. PubMed ID: 103112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some aspects of the changes induced by chronic barbital treatments in the male rat.
    Wahlström G
    Drug Alcohol Depend; 1979; 4(3-4):221-33. PubMed ID: 575087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between spontaneous convulsions and tolerance to hexobarbital in the abstinence after chronic barbital treatments in the rat.
    Wahlström G
    Life Sci; 1976 Dec; 19(12):1817-26. PubMed ID: 1034185
    [No Abstract]   [Full Text] [Related]  

  • 6. The interaction between pilocarpine and hexobarbital in male rats.
    Wahlström G
    Psychopharmacology (Berl); 1976 Sep; 49(2):159-66. PubMed ID: 825902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity pattern and convulsions in the abstinence period after barbital treatment in the rat.
    Wahlström G; Larsson R
    Pharmacol Biochem Behav; 1977 Feb; 6(2):187-92. PubMed ID: 558618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance, physical dependence and changes in muscarinic receptor binding sites after chronic ethanol treatment in the rat.
    Nordberg A; Wahlström G
    Life Sci; 1982 Jul; 31(3):277-87. PubMed ID: 6889663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to hexobarbital and supersensitivity to pilocarpine after chronic barbital treatments in the rat.
    Wahlstrŏm G; Ekwall T
    Eur J Pharmacol; 1976 Jul; 38(1):123-9. PubMed ID: 954821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on acute tolerance to ethanol in the abstinence period after long-term barbital treatment in the rat.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):152-60. PubMed ID: 573957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atropine in the abstinence after chronic barbital treatment in the rat.
    Wahlström G
    Pharmacol Biochem Behav; 1980; 13 Suppl 1():249-55. PubMed ID: 7195576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in populations of cholinergic binding sites in brain after chronic exposure to barbital in rats.
    Nordberg A; Wahlström G
    Brain Res; 1982 Aug; 246(1):105-12. PubMed ID: 7127080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to hexobarbital induced by short-term treatments with diazepam and tested with an EEG-threshold test in male rats.
    Carlsson S; Wahlström G
    Pharmacol Toxicol; 1993 Feb; 72(2):134-8. PubMed ID: 8474966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barbital alteration of central nervous system sensitivity to hexobarbital in the rat.
    Schnell RC; Stoll RE; Prosser TD
    Psychopharmacology (Berl); 1976 May; 47(1):93-6. PubMed ID: 959468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on interactions between striatal dopaminergic and cholinergic mechanisms in the early abstinence after chronic treatment with barbital in the rat.
    Persson SA; Wahlström G
    Subst Alcohol Actions Misuse; 1984; 5(3):149-57. PubMed ID: 6438820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drinking and cholinergic mechanisms in the abstinence after chronic barbital treatments.
    Wahlström G
    Scand J Psychol; 1982; Suppl 1():79-84. PubMed ID: 7187992
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticonvulsive activity of several excitatory amino acid antagonists against barbital withdrawal-induced spontaneous convulsions.
    McCaslin PP; Morgan WW
    Eur J Pharmacol; 1988 Mar; 147(3):381-6. PubMed ID: 3378564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term forced oral barbital administration on endogenous acetylcholine in different regions of rat brain.
    Nordberg A; Wahlström G
    Eur J Pharmacol; 1977 Jun; 43(3):237-42. PubMed ID: 559577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of withdrawal from long-term barbital treatment on open-field behaviour and seizure susceptibility of rats.
    Palermo-Neto J; De Lima TC
    Neuropharmacology; 1982 Mar; 21(3):277-81. PubMed ID: 6122187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between atropine and the steric isomers of hexobarbital in normal rats and rats made tolerant to barbital.
    Wahlström G
    Eur J Pharmacol; 1979 Nov; 59(3-4):219-25. PubMed ID: 527647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.